Intrauterine Insemination Devices Market size was valued at USD 41.52 Billion in 2023 and is likely to reach USD 67.43 Billion by the end of 2036, expanding at around 3.8% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of intrauterine insemination devices is assessed at USD 42.94 Billion. The growth of the market can be attributed to the increasing occurrence of infertility across the world. Intrauterine insemination devices are used to test infertility by placing sperm directly in the uterus when an ovary releases one or more eggs. The main purpose of intrauterine insemination devices is to increase the chances of fertility. It is estimated that over 14% of couples worldwide are unable to conceive, compelling the global demand for intrauterine insemination devices.
Intrauterine insemination is an artificial process in which the sperm is placed in the upper uterine cavity to ease conception. The goal of the procedure is to increase the number of sperms inside a woman’s uterus, thereby raising the chances of impregnation. Catheters, intrauterine insemination media, and sperm wash are some intrauterine insemination devices. They are used when women are unable to get pregnant owing to a condition called endometriosis. Endometriosis afflicts about 10% of women and girls of childbearing age around the world, according to data from the World Health Organization (WHO). This is predicted to promote the growth of the global intrauterine insemination devices market. Hence, all these factors are anticipated to propel the growth of the market during the forecast period.
Growth Drivers
Increasing Incidence of PCOS– The Centers for Disease Control and Prevention (CDC) estimates that around 6% to 12% of women in the United States suffer from polycystic ovary syndrome, which amounts to roughly 5 million of them.
PCOS causes hyperandrogenism and oligo-anovulation that are directly associated with infertility. A large number of women suffer from PCOS across the globe. For instance, approximately 75% of women worldwide are living with infertility owing to PCOS. This is considered to be one of the main reasons for infertility in women and it is expected to increase the global intrauterine insemination devices market size.
Surge in Drug Abuse – Almost 11 million people around the world consume psychoactive drugs, as per the data collected by the World Health Organization (WHO). This causes infertility in many couples and is estimated to drive the intrauterine insemination devices market growth. It has been observed that extreme consumption of drugs can reduce the chance of having a baby by reducing fertility in both men and women.
Increment in Smoking Habits – In 2019, there were more than a billion smokers, according to a comprehensive study on worldwide smoking trends. This affects fertility and is predicted to increase the demand for artificial insemination. Smoking habits are scientifically proven that can make the process of conceiving a child quite complex since exposure to smoking can damage the reproductive system and harm the DNA in sperm.
Rise in the Number of Cancer Cases and Chemotherapy – Cancer treatments may lead to poor reproductive health. According to the National Cancer Institute, cancer incidence is calculated to be approximately 442 per 100,000 people globally every year. Chemotherapies have been observed to affect ovaries by making them stop releasing estrogen and eggs.
Higher Prevalence of Obesity – As of 2019, there were about 2500 million overweight people around the World. Obesity affects nearly 39% of the global population. This condition is predicted to boost the global intrauterine insemination devices market as obesity may lead to the inability to conceive. Additionally, 6% of women worldwide experience fertility struggles owing to obesity.
Challenges
|
Base Year |
2023 |
|
Forecast Year |
2024-2036 |
|
CAGR |
3.8% |
|
Base Year Market Size (2023) |
USD 41.52 Billion |
|
Forecast Year Market Size (2036) |
USD 67.43 Billion |
|
Regional Scope |
|
End-user (Hospitals, IVF Clinics)
The global intrauterine insemination devices market is segmented and analyzed for demand and supply by end-users in hospitals and IVF clinics. Out of these segments, the IVF clinics segment is estimated to gain the largest market share in the year 2036. The growth of the segment can be attributed to the increasing count of cutting-edge IVF clinics cropping up across the world. Furthermore, there is a growing demand for assisted reproductive technology (ART) from childless and homosexual couples, which is anticipated to propel the segment growth. According to a report published by CDC, about 489 clinics in the United States executed 3,226 ART procedures for every million women of reproductive age. Furthermore, IVF clinics are often visited since they have excellent provisions and access to sperm banks. Hence, all these factors are expected to influence the market segment growth positively over the forecast period.
Product Type {IUI Catheters (Curved, Flexible, Straight)
The global intrauterine insemination devices market is also segmented and analyzed for demand and supply by product type into IUI catheters, IUI media, and sperm wash. Among these three segments, the IUI media segment is expected to garner a significant share in 2036. IUI media is a treatment process for people living with infertility owing to low sperm count, low semen volume, lack of cervical mucus, endometriosis, unexplained infertility, anti-sperm antibodies, and others. IUI media is highly preferred by couples since it is less invasive and less expensive than other alternatives such as ICSI and any in vitro fertilization banking services. IUI media does not put extra weight on the body and is great for providing quality sperm since it removes immature germ cells, infectious agents, non-motile spermatozoa, and antigenic proteins. Hence, all these major benefits of IUI media are anticipated to propel the segment growth over the forecast period.
Our in-depth analysis of the global market includes the following segments:
|
By Product Type |
|
|
By End User |
|
North American Market Forecast
The North American intrauterine insemination devices market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2036. The growth of the market can be attributed majorly to the increasing incidence of infertility across the region. The growth of the market can be accounted for by the surge in the number of infertility treatment clinics being set up in developing countries to cater to the growing demand for artificial insemination in the region. For instance, in every 4 women in the USA, 1 of them suffers from infertility which sums up to 25% of the total population of heterosexual women. While this rate is increasing exponentially with a total rate of around 11% annually. Furthermore, the spike in drug abuse in the region by adults and increasing smoking habits are further anticipated to expand the market size over the forecast period. Hence, all these factors are estimated to boost the growth of the market during the forecast period.
APAC Market Statistics
Furthermore, the global intrauterine insemination devices market is also anticipated to hold the second-largest share in the Asia Pacific region over the forecast period. The growing awareness of assisted reproductive techniques (ARTs) to conceive backed by the growing prevalence of infertility is expected to hike the market growth during the forecast period. Almost 28 million couples in India preferred alternative treatment options for conception. Furthermore, over 1600 IVF clinics and hospitals perform an average of 225,000 ART cycles in a year in India. Additionally, the growing prevalence of drug abuse in the region coupled with upsurged smoking habits is also expected to fuel the market growth in the projected timeframe.
Cook Group Incorporated has innovated a Benchtop Incubator called the MINC+ which includes a DishTrace platform with a touchscreen and a software program to provide a wide range of dish-data management tools to embryologists.
The Cooper Companies, Inc. announced its acquisition of Generate Life Sciences to provide better products and services such as the provision of donor eggs and sperm, cryopreservation, and newborn stem cell storage to fertility clinics and obstetricians/ gynecologists.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?